← 治験一覧に戻る
日本人1型糖尿病患者を対象としたLY900014の研究
基本情報
- NCT ID
- NCT03407118
- ステータス
- 完了
- 試験のフェーズ
- 第1相
- 試験タイプ
- 介入
- 目標被験者数
- 31
- 治験依頼者名
- Eli Lilly and Company
概要
This study will compare LY900014, a drug that lowers blood sugar, with insulin lispro (Humalog). Both drugs will be given by injection under the skin of the abdomen. This study will be conducted in participants with type 1 diabetes to investigate how quickly and how much LY900014 is absorbed and the effect of LY900014 on blood sugar levels in comparison with insulin lispro. The study will last about 3 to 6 weeks for each participant, not including screening.
対象疾患
Diabetes Mellitus, Type 1
介入
LY900014(DRUG)
Insulin Lispro(DRUG)
依頼者（Sponsor）
日本イーライリリー株式会社(INDUSTRY)